News

A lead investigator explains the findings of how active choice intervention in patient's electronic health records helps to increase vaccination rates.

Re-establishing the doctor-patient bond is critical, especially in an era of more informed patients and increasing physician burnout.

The FDA has approved 2 new dosages of the pain reliever that combines benzhydrocodone and acetaminophen.

The WEB Aneurysm Embolization System is designed to treat intracranial wide neck bifurcation aneurysms.

New research finds patients face a higher risk of pneumonia if they are taking opioids. The danger is even more pronounced for patients living with HIV.

The study implies that B-cell depletion by rituximab therapy may be therapeutically beneficial in patients with secondary progressive multiple sclerosis.

A new analysis finds racial and ethnic disparities vary significantly from state to state when it comes to sexually transmitted infection rates among men who have sex with men.

Patient and caregiver assessments should be considered alongside clinician assessments during tardive dyskinesia screening procedures, as they may differ.

It remains unclear whether clozapine treats or suppresses the symptoms of tardive dyskinesia.

Sustained virological response with the treatment of HCV infection is associated with reduced mortality from extrahepatic complications, accoridng to a new study.

Why obstetricians and gynecologists need to consider the stigmas and telling signs of sexual dysfunction in female patients.

Prenatal exposure to the antiepileptic drug valproate is associated with increased risk for ADHD independent of its link to congenital malformations.

While the absolute risk of therapy-related blood cancers is low, the treatment is often intensive and linked to substantial morbidity.

A new survey study found that less than half of food allergies reported by adults have actually been diagnosed by a physician.

Antiepileptic drug levels that remain subtherapeutic—despite the correct dose and proper adherence—can improve with adjustment for pharmacokinetics.

A large Asian population study supports the link between HCV and parkinsonism in that region, and associated treating HCV with reduced risk.

The phase 3 CAMP-1 and CAMP-2 clinical trials evaluating VP-102 for the treatment of molluscum contagiosum demonstrated clinical and statistical significance.

In a 10-patient study, sutimlimab halted the destruction of red blood cells in patients with cold agglutinin disease.

Common infusion-associated adverse reactions with ocrelizumab for multiple sclerosis were substantially reduced with strategic premedication.

In theory, the combination of ART and PrEP would be enough to virtually eradicate HIV. In the real world, they’re falling well short.

Candidate vaccines for respiratory syncytial virus may also impact pediatric asthma and wheezing, but the required sample sizes are too large for a clinical trial.

A sham-controlled trial demonstrated that a novel at-home administration of transcranial stimulation reduced fatigue in multiple sclerosis.

The FDA has approved dasatinib (Sprycel) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).

The polio-like AFM is an emerging health concern, with outbreaks documented since 2012.

Overall, a new Florida State study found that 13-17 year-olds are behind all children in influenza vaccination rates.

The Pediatric Asthma Risk Score could improve on the track record of the Asthma Predictive Index, which in the past has been shown to poorly predict who would develop the condition.

A single blood eosinophil measurement may not be adequate for determining whether an asthma patient can have elevated blood eosinophils.

MD Magazine's most popular stories this year ranged from new clinical insights, to physician-submitted columns, to perspectives on burnout in the workplace.